The C-ETS2-mediated TFEB-induction mechanism may play a central role in the response of neurons to oxidative stress during the early stages of neurodegenerative disease, thus revealing a new avenue of neuroprotective therapy in neurodegenerative diseases. This evidence concerns the gene TFEB and neurodegenerative disease.